The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus

BACKGROUND: Diabetes mellitus (DM) is considered as a risk factor for the progress of liver diseases. After tissue damage, there is the highest amplitude of ubiquitously sterile inflammatory response in the liver, resulting in a major clinical consequence concerning a high prevalence of steatohepati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Transl Med
Glavni autori: Leng, Weiling, Wu, Mingxia, Pan, Hang, Lei, Xiaotian, Chen, Liu, Wu, Qinan, Ouyang, Xinshou, Liang, Ziwen
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803170/
https://ncbi.nlm.nih.gov/pubmed/31700865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.09.03
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items